数据链接：
官方服务：
资源简介：
MPRs of four anti-diabetic medicines with IRP.
应用场景：
创建时间：
2019-10-16
相关数据集
Supplementary materials: Cost–effectiveness and cost–benefit analysis of oliceridine in the treatment of acute pain
These are peer-reviewed supplementary tables for the article ' Cost–effectiveness and cost-benefit analysis of oliceridine in the treatment of acute pain ' published in the Jo
DataCite Commons2026-04-29 更新150
Modelo de Custo-efetividade dos medicamentos para melanoma metastático
Esse modelo foi desenhado no software treeage e foi criado um modelo tipo player onde indivíduos que não possuem o software podem fazer o download no site de uma versão do visualizador e abrir o arqui
NIAID Data Ecosystem40
Results of scenario analyses for sCRT population.
Objective The effectiveness of sugemalimab vs. placebo in post-chemoradiotherapy patients with locally advanced, unresectable stage III NSCLC has been demonstrated and approved by China National Medic
NIAID Data Ecosystem20
The cost-effectiveness of metformin in pre-diabetics: a systematic literature review of health economic evaluations
Objectives : Our aim was to systematically identify and appraise cost-effectiveness studies of metformin in prediabetic subjects. Methods : A systematic literature review was conducted and
DataCite Commons2020-08-26 更新70
Input parameters for the base-case analysis.
Background Expanding the indication of already approved immuno-oncology drugs presents treatment opportunities for patients but also strains healthcare systems. Cost-based pricing models are discussed
NIAID Data Ecosystem30
